New York State Psychiatric Institute: Obsessive-Compulsive Disorder trials
The registry lists 24 Obsessive-Compulsive Disorder studies with New York State Psychiatric Institute as lead sponsor. 1 are open to participants now and 14 have results posted.
Phase 1 5Phase 2 13Phase 4 1No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Helping Adults With Obsessive-Compulsive Disorder Succeed at WorkRecruitingNCT07124780Not applicable
- Effects of Marijuana on Symptoms of OCDCompletedNCT03274440Phase 1/2Results posted
- Cannabinoid Medication for Adults With OCDCompletedNCT02911324Phase 1/2Results posted
- Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)CompletedNCT02422290Phase 1/2Results posted
- Overlapping Neural Circuits in Pediatric OCDCompletedNCT02421315Not applicableResults posted
- Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive DisorderCompletedNCT02267629Phase 2Results posted
- Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCDTerminatedNCT02206776Phase 2Results posted
- Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)CompletedNCT02062658Phase 2Results posted
- Novel Medication Strategies Targeting Brain Mechanisms in Pediatric OCDCompletedNCT01695291Phase 2Results posted
- D-Cycloserine Augmentation to CBT With Exposure and Response Prevention in Adults and Adolescents With OCDCompletedNCT01172873Not applicableResults posted
- Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD)CompletedNCT01100255Phase 2Results posted
- Memantine Augmentation in Treatment-Resistant Adults With Obsessive-Compulsive DisorderCompletedNCT00956085Phase 2Results posted
- Pilot Study of Minocycline (NPL-2003) in Adults With Obsessive-Compulsive Disorder (OCD)CompletedNCT00728923Phase 2Results posted
- Risperidone or Cognitive-Behavioral Therapy for Improving Medication Treatment for Obsessive-compulsive DisorderCompletedNCT00389493Not applicableResults posted
- Transcranial Magnetic Stimulation (TMS) and Obsessive Compulsive Disorder (OCD)CompletedNCT00106249Phase 2Results posted
- Multimodal Assessment of Cannabinoid Target Engagement in Adults With Obsessive-Compulsive DisorderWithdrawnNCT04880278Phase 1/2
- Neuroinflammation in Patients With OCDSuspendedNCT04786548Phase 2
- Feasibility, Acceptability, and Preliminary Efficacy of a Mobile App (nOCD) for OCDCompletedNCT03476902Not applicable
- Brief Intervention for OCD FearsWithdrawnNCT02790710Phase 4
- Personalized Computerized Inhibitory Control Training for OCDCompletedNCT02378896Not applicable
- Control and Reward Circuits in Obsessive Compulsive DisorderCompletedNCT02221518Not applicable
- Attaining and Maintaining Wellness in Obsessive-compulsive DisorderCompletedNCT01686087Not applicable
- Cognitive Behavioral Therapy Plus Motivational Interviewing for Treatment of Obsessive-Compulsive DisorderCompletedNCT00316316Phase 1
- Cognitive Behavioral Therapy Plus Drug Treatment for Obsessive Compulsive DisorderCompletedNCT00045903Not applicable